Compare Select Medical Holdings Corporation (SEM) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Select Medical Holdings Corporation vs TransMedics Group Inc — how do they compare? Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| SEM | TMDX | |
|---|---|---|
Market Cap | $2.05B | $2.54B |
Sector | Health | Technology |
52-Week High | $16.66 | $150.42 |
52-Week Low | $11.77 | $61.99 |
Enterprise Value | $5.01B | $2.94B |
Dividend Yield | 1.51% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
